Evidence map›Paper›PMID 27505078›Full record

ReviewAnnals of the New York Academy of Sciences2016

Multi-inhibitor prodrug constructs for simultaneous delivery of anti-inflammatory agents to mustard-induced skin injury.

Carl J Lacey, Irene Wohlman, Christophe Guillon, Jaya Saxena, Cynthia Fianu-Velgus, Erik Aponte, Sherri C Young, Diane E Heck, Laurie B Joseph, Jeffrey D Laskin and 1 more

Abstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Carl J LaceyDepartment of Chemistry, Lehigh University, Bethlehem, Pennsylvania.
Irene WohlmanDepartment of Pharmacology and Toxicology, Rutgers University, New Brunswick, New Jersey.
Christophe GuillonDepartment of Chemistry, Lehigh University, Bethlehem, Pennsylvania.
Jaya SaxenaDepartment of Chemistry, Lehigh University, Bethlehem, Pennsylvania.
Cynthia Fianu-VelgusDepartment of Chemistry, Lehigh University, Bethlehem, Pennsylvania.
Erik AponteDepartment of Chemistry, Lehigh University, Bethlehem, Pennsylvania.
Sherri C YoungDepartment of Chemistry, Muhlenberg College, Allentown, Pennsylvania.
Diane E HeckDepartment of Environmental Health Science, New York Medical College, Valhalla, New York.
Laurie B JosephDepartment of Pharmacology and Toxicology, Rutgers University, New Brunswick, New Jersey.
Jeffrey D LaskinDepartment of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, New Jersey.
Ned D HeindelDepartment of Chemistry, Lehigh University, Bethlehem, Pennsylvania. ndh0@lehigh.edu.
Lehigh University · USRutgers, The State University of New Jersey · USEnvironmental and Occupational Health Sciences Institute · USMuhlenberg College · USNew York Medical College · US

Funding

UMDNJ/Rutgers University CounterACT Research Center of ExcellenceU54AR055073 · NIAMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI LASKIN, JEFFREY D · 2006 to 2024
$71.4M
NIAMS NIH HHS U54 AR055073
6 · The paper itself

Abstract

The molecular pathology of sulfur mustard injury is complex, with at least nine inflammation-related enzymes and receptors upregulated in the zone of the insult. A new approach wherein inhibitors of these targets have been linked by hydrolyzable bonds, either one to one or via separate preattachment to a carrier molecule, has been shown to significantly enhance the therapeutic response compared with the individual agents. This article reviews the published work of the authors in this drug development domain over the last 8 years.

Indexed as

AnimalsAnti-Inflammatory AgentsChemical Warfare AgentsCholinesterase InhibitorsCyclooxygenase InhibitorsDrug Delivery SystemsDrug DiscoveryHumansMustard GasProdrugsSkinAnti-Inflammatory AgentsChemical Warfare AgentsCholinesterase InhibitorsCyclooxygenase InhibitorsMustard GasProdrugsbifunctionalschloroethylethylsulfideinflammationphorbol esterskinsulfur mustardvesicants

Identifiers

PMID27505078
PMCPMC5063683
OpenAlexW2508560495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.